About Indiglove Pharma Private Limited
Data last updated:
Indiglove Pharma Private Limited is a private limited company based in Haltu, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U52609WB2019PTC233791. Its GSTIN is 19AAFCI3989N1ZN (West Bengal).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Sayantani Sen and Devansh Chakraborty.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at C/O – Arijit Roy 458 Kalikapur Road Ground Floor P.S. – E. Jadavpur, Haltu, West Bengal, India – 700078.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.29 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.97 Lakh (net margin 1.3%) and EBITDA of ₹5.3 Lakh (EBITDA margin 2.3%).
As per MCA filings, the company has open charges of ₹75 Lakh on record.
For more details, the company can be reached via its website indiglovepharma.com.
Company details
Contact details
Indiglove Pharma Private Limited's registered office is in Haltu, West Bengal. Its website is indiglovepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O – Arijit Roy 458 Kalikapur Road Ground Floor P.S. – E. Jadavpur, Haltu, West Bengal, India – 700078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Indiglove Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indiglove Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Indiglove Pharma Private Limited, buy the company report.
Financials of Indiglove Pharma Private Limited
FY 2021 filings availableIndiglove Pharma Private Limited reported revenue of ₹2.29 Cr (up 534% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 534% in the latest year. EBITDA rose 72% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹2.29 Cr | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹5.3 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹2.97 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.3% | |
| Net Profit Margin | 1.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Indiglove Pharma Private Limited, buy the company report.
Board of directors of Indiglove Pharma Private Limited
Indiglove Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sayantani Sen Also directs: Emblence Industries Private Limited | Director | 13 Feb 2020 | 6 Years 8 Months | Current |
| Devansh Chakraborty | Director | 05 Sep 2019 | 7 Years 1 Months | Current |
Peer comparison
Indiglove Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| V2shine Pharma Private Limited | ₹2.29 Cr (FY 2024) | 6.0% | Nagercoil, Tamil Nadu, India | |||
| Destin Laboratories Private Limited | ₹2.29 Cr (FY 2025) | 0.0% | Karnal, Haryana, India | |||
| Paira Solar System Private Limited | ₹2.29 Cr (FY 2025) | 95.0% | Nawabganj, Uttar Pradesh, India | |||
| Jaskwellness Private Limited | ₹2.29 Cr (FY 2025) | 41.0% | Jaipur, Rajasthan, India | |||
| Seagear Marine Supplies Private Limited | ₹2.29 Cr (FY 2025) | -10.0% | Thane, Maharashtra, India | |||
| Indiglove Pharma Private Limitedthis company | ₹2.29 Cr (FY 2021) | ₹2.97 Lakh | 1.3% | 534.0% | Haltu, West Bengal, India | |
| Times Drugs and Pharmaceticals Private Limited | ₹2.29 Cr (FY 2025) | 3.0% | Ghaziabad, Uttar Pradesh, India | |||
| Midnapore Tyre Retreaders Pvt Ltd | ₹2.29 Cr (FY 2024) | 78.0% | Kolkata, West Bengal, India | |||
| Greek Pharma Private Limited | ₹2.29 Cr (FY 2025) | 208.0% | Panchkula, Haryana, India | |||
| Zeliant Pencils Private Limited | ₹2.29 Cr (FY 2017) | -16.0% | Vapi, Gujarat, India | |||
| Shri Sai Metal Pressing Private Limited | ₹2.29 Cr (FY 2025) | -28.0% | Pithampur, Madhya Pradesh, India |
To see the full peer comparison of Indiglove Pharma Private Limited, buy the company report.
Auditor
Indiglove Pharma Private Limited is audited by A B R S & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A B R S & ASSOCIATES | FY 2021 | 017964C |
Shareholding
The shareholding of Indiglove Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Indiglove Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2020 | 100347206 | State Bank of India | ₹75 Lakh | Open |
To see the full charge records of Indiglove Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Indiglove Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indiglove Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indiglove Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAFCI3989N1ZN | West Bengal | Active | 02 Oct 2019 |
To see the full GST registrations and return filing status of Indiglove Pharma Private Limited, buy the company report.
Recent activity
Indiglove Pharma Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Debasish Chandra ceased to be Director on 06 Apr 2021.
Frequently asked questions
Indiglove Pharma is an active private limited company based in Haltu, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 September 2019 (7+ years old) and is registered under CIN U52609WB2019PTC233791.
Indiglove Pharma has 2 current directors:
- Sayantani Sen - Director
- Devansh Chakraborty - Director
The latest financial statements of Indiglove Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Indiglove Pharma is 19AAFCI3989N1ZN, registered in West Bengal.
The CIN (Corporate Identification Number) of Indiglove Pharma is U52609WB2019PTC233791. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indiglove Pharma was incorporated on 05 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Indiglove Pharma by revenue are V2shine Pharma Private Limited, Destin Laboratories Private Limited, Paira Solar System Private Limited, Jaskwellness Private Limited, Seagear Marine Supplies Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Debasish Chandra ceased to be Director on 06 Apr 2021. Sandip Kanti Gayen ceased to be Director on 06 Apr 2021. Sayantani Sen was appointed as Director on 13 Feb 2020. Indiglove Pharma has 5 board changes on record in total.
Indiglove Pharma can be reached through the website indiglovepharma.com. Its registered office is in Haltu, West Bengal, India.
The registered office of Indiglove Pharma is at CO – Arijit Roy 458 Kalikapur Road Ground Floor P.S. – E. Jadavpur, Haltu, West Bengal, India – 700078.
Indiglove Pharma operates in the pharma industry, in the drug formulation and development segment.